{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:24:22Z","timestamp":1773818662518,"version":"3.50.1"},"reference-count":36,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T00:00:00Z","timestamp":1687651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Objectives: The role of surgical metastasectomy (MST) in solitary or oligometastasis from renal cell carcinoma (RCC) and its impact on survival outcomes remains poorly addressed. We evaluated the impact of MST on overall survival (OS) in patients with oligometastatic (m)RCC. Materials and methods: The institutional renal cancer prospective database was examined for cases treated with partial or radical nephrectomy who developed metastatic disease during follow-up. Patients with evidence of clinical metastasis at first diagnosis were excluded. Patients considered unfit for MST received systemic treatment (ST); all others received MST. The impact of MST vs. the ST only cohort was assessed with the Kaplan\u2013Meier method. Age, gender, bilaterality, histology, AJCC stage of primary tumor, surgical margins, local vs. distant metastasis and MST were included in univariable and multivariable regression analyses to assess the predictors of OS. Results: Overall, at a median follow-up of 16 months after primary treatment, 168 patients with RCC developed asynchronous metastasis at the adrenal gland, lung, liver, spleen, peritoneal, renal fossa, bone, nodes, brain and thyroid gland. Nine patients unfit for any treatment were excluded. The site of metastasis was treated with surgical MST (77\/159, 48.4%), with or without previous or subsequent ST, while 82\/159 cases (51.2%) received ST only. The 2-year, 5-year and 10-year OS probabilities were 93.8%, 82.8% and 79.5%, respectively. After multivariable analysis, MST and the primary tumor AJCC stage were independent predictors of OS probabilities (p = 0.019 and p = 0.035, respectively). After Kaplan\u2013Meier analysis, MST significantly improved OS probabilities versus patients receiving ST (p &lt; 0.001). Limitations: The main drawbacks of our research were the small sample size from a single-tertiary referral institution, as well as the absent or different ST lines in the cohort of patients receiving MST. Conclusions: When an NED status is achievable, surgical MST of mRCC significantly impacts OS, delaying and not precluding further subsequent ST.<\/jats:p>","DOI":"10.3390\/cancers15133332","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T03:14:56Z","timestamp":1687749296000},"page":"3332","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Impact of Metastasectomy on Survival Outcomes of Renal Cell Carcinoma: A 10-Year Single Center Experience"],"prefix":"10.3390","volume":"15","author":[{"given":"Mariaconsiglia","family":"Ferriero","sequence":"first","affiliation":[{"name":"Department of Urology, IRCCS \u201cRegina Elena\u201d National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loris","family":"Cacciatore","sequence":"additional","affiliation":[{"name":"Department of Urology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Ochoa","sequence":"additional","affiliation":[{"name":"Department of Urology, IRCCS \u201cRegina Elena\u201d National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Mastroianni","sequence":"additional","affiliation":[{"name":"Department of Urology, IRCCS \u201cRegina Elena\u201d National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4480-9090","authenticated-orcid":false,"given":"Gabriele","family":"Tuderti","sequence":"additional","affiliation":[{"name":"Department of Urology, IRCCS \u201cRegina Elena\u201d National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1638-0987","authenticated-orcid":false,"given":"Manuela","family":"Costantini","sequence":"additional","affiliation":[{"name":"Department of Urology, IRCCS \u201cRegina Elena\u201d National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Anceschi","sequence":"additional","affiliation":[{"name":"Department of Urology, IRCCS \u201cRegina Elena\u201d National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Misuraca","sequence":"additional","affiliation":[{"name":"Department of Urology, IRCCS \u201cRegina Elena\u201d National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Brassetti","sequence":"additional","affiliation":[{"name":"Department of Urology, IRCCS \u201cRegina Elena\u201d National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Guaglianone","sequence":"additional","affiliation":[{"name":"Department of Urology, IRCCS \u201cRegina Elena\u201d National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5139-9993","authenticated-orcid":false,"given":"Alfredo Maria","family":"Bove","sequence":"additional","affiliation":[{"name":"Department of Urology, IRCCS \u201cRegina Elena\u201d National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9566-7243","authenticated-orcid":false,"given":"Rocco","family":"Papalia","sequence":"additional","affiliation":[{"name":"Department of Urology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Gallucci","sequence":"additional","affiliation":[{"name":"Department of Urology, IRCCS \u201cRegina Elena\u201d National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4868-9025","authenticated-orcid":false,"given":"Giuseppe","family":"Simone","sequence":"additional","affiliation":[{"name":"Department of Urology, IRCCS \u201cRegina Elena\u201d National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","article-title":"European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update","volume":"82","author":"Ljungberg","year":"2022","journal-title":"Eur. Urol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00345-016-1773-y","article-title":"Renal Cell Carcinoma Recurrences and Metastases in Primary Non-Metastatic Patients: A Population-Based Study","volume":"34","author":"Dabestani","year":"2016","journal-title":"World J. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1586\/14737140.7.6.847","article-title":"Patterns of Recurrence and Surveillance Strategies for Renal Cell Carcinoma Following Surgical Resection","volume":"7","author":"Breda","year":"2007","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ferriero, M., Prata, F., Mastroianni, R., De Nunzio, C., Tema, G., Tuderti, G., Bove, A.M., Anceschi, U., Brassetti, A., and Misuraca, L. (2022). The Impact of Locoregional Treatments for Metastatic Castration Resistant Prostate Cancer on Disease Progression: Real Life Experience from a Multicenter Cohort. Prostate Cancer Prostatic Dis.","DOI":"10.1038\/s41391-022-00623-5"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/jso.21504","article-title":"Thermoablation of Colorectal Liver Metastasis","volume":"101","author":"Kulaylat","year":"2010","journal-title":"J. Surg. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41416-020-01175-y","article-title":"Treatment Strategies for Breast Cancer Brain Metastases","volume":"124","author":"Bailleux","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ncl.2021.11.002","article-title":"Surgery, Stereotactic Radiosurgery, and Systemic Therapy in the Management of Operable Brain Metastasis","volume":"40","author":"Kotecha","year":"2022","journal-title":"Neurol. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jvir.2012.03.002","article-title":"Percutaneous Cryoablation of Metastatic Renal Cell Carcinoma for Local Tumor Control: Feasibility, Outcomes, and Estimated Cost-Effectiveness for Palliation","volume":"23","author":"Bang","year":"2012","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/0284186X.2014.939298","article-title":"Outcomes of Stereotactic Radiotherapy for Cranial and Extracranial Metastatic Renal Cell Carcinoma: A Systematic Review","volume":"54","author":"Kothari","year":"2015","journal-title":"Acta Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.juro.2016.07.079","article-title":"Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis","volume":"197","author":"Zaid","year":"2017","journal-title":"J. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Matuszczak, M., Kilja\u0144czyk, A., and Salagierski, M. (2023). Surgical Approach in Metastatic Renal Cell Carcinoma: A Literature Review. Cancers, 15.","DOI":"10.3390\/cancers15061804"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1803675","article-title":"Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma","volume":"379","author":"Ravaud","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1200\/JCO.1998.16.6.2261","article-title":"Resection of Metastatic Renal Cell Carcinoma","volume":"16","author":"Kavolius","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"799.e1","DOI":"10.1016\/j.urolonc.2020.07.021","article-title":"Outcomes of Complete Metastasectomy in Metastatic Renal Cell Carcinoma Patients: The Canadian Kidney Cancer Information System Experience","volume":"38","author":"Dragomir","year":"2020","journal-title":"Urol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/cncr.25836","article-title":"Survival after Complete Surgical Resection of Multiple Metastases from Renal Cell Carcinoma","volume":"117","author":"Alt","year":"2011","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5114\/wo.2020.93679","article-title":"Adrenal Metastases\u2014Long-Term Results of Surgical Treatment, Single-Centre Experience","volume":"24","author":"Samsel","year":"2020","journal-title":"Wsp\u00f3\u0142czesna Onkol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.juro.2015.02.2943","article-title":"Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy","volume":"194","author":"Thomas","year":"2015","journal-title":"J. Urol."},{"key":"ref_18","first-page":"42.e7","article-title":"Renal Fossa Recurrence after Radical Nephrectomy: Current Management, and Oncological Outcomes","volume":"38","author":"Romeo","year":"2020","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.eururo.2017.03.005","article-title":"Complications After Metastasectomy for Renal Cell Carcinoma\u2014A Population-Based Assessment","volume":"72","author":"Meyer","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jso.23473","article-title":"Local Recurrence after Radical Nephrectomy for Kidney Cancer: Management and Prediction of Outcomes. A Multi-Institutional Study: Local Recurrence After Radical Nephrectomy","volume":"109","author":"Paparel","year":"2014","journal-title":"J. Surg. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.surg.2021.12.003","article-title":"Robot-Assisted versus Conventional Laparoscopic Adrenalectomy: Results from the EUROCRINE Surgical Registry","volume":"171","author":"Vatansever","year":"2022","journal-title":"Surgery"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/JU.0000000000000488","article-title":"Complete Surgical Metastasectomy of Renal Cell Carcinoma in the Post-Cytokine Era","volume":"203","author":"Lyon","year":"2020","journal-title":"J. Urol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.ejso.2022.01.024","article-title":"Off-clamp robot-assisted partial nephrectomy for purely hilar tumors: Technique, perioperative, oncologic and functional outcomes from a single center series","volume":"48","author":"Ferriero","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.eururo.2018.09.015","article-title":"\u201cRide the Green Light\u201d: Indocyanine Green-marked Off-clamp Robotic Partial Nephrectomy for Totally Endophytic Renal Masses","volume":"75","author":"Simone","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1016\/j.clgc.2022.03.001","article-title":"The Distribution of Metastatic Renal Cell Carcinoma by Presenting Tumor Stage in the Modern Era","volume":"20","author":"Sharp","year":"2022","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.eururo.2018.01.005","article-title":"Predicting Oncologic Outcomes in Renal Cell Carcinoma after Surgery","volume":"73","author":"Leibovich","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/cncr.21331","article-title":"Comparison of Predictive Accuracy of Four Prognostic Models for Nonmetastatic Renal Cell Carcinoma after Nephrectomy: A Multicenter European Study","volume":"104","author":"Cindolo","year":"2005","journal-title":"Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-5347(05)66077-6","article-title":"A Postoperative Prognostic Nomogram for Renal Cell Carcinoma","volume":"166","author":"Kattan","year":"2001","journal-title":"J. Urol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.ju.0000165572.38887.da","article-title":"Postoperative Surveillance Protocol for Patients with Localized and Locally Advanced Renal Cell Carcinoma Based on a Validated Prognostic Nomogram and Risk Group Stratification System","volume":"174","author":"Lam","year":"2005","journal-title":"J. Urol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.eururo.2016.05.034","article-title":"Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients","volume":"71","author":"Parker","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/j.clgc.2019.02.008","article-title":"Synchronous Bilateral RCC Is Associated with Poor Recurrence-Free Survival Compared with Unilateral RCC: A Single-Center Study with Propensity Score Matching Analysis","volume":"17","author":"Kim","year":"2019","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/j.clgc.2018.08.004","article-title":"Positive Surgical Margins Predict Progression-Free Survival After Nephron-Sparing Surgery for Renal Cell Carcinoma: Results from a Single Center Cohort of 459 Cases with a Minimum Follow-up of 5 Years","volume":"17","author":"Tellini","year":"2019","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"945166","DOI":"10.3389\/fonc.2022.945166","article-title":"Positive Surgical Margins May Not Affect the Survival of Patients with Renal Cell Carcinoma after Partial Nephrectomy: A Meta-Analysis Based on 39 Studies","volume":"12","author":"Bai","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.2217\/fon-2017-0175","article-title":"Clinical correlates and prognostic value of different metastatic sites in metastatic renal cell carcinoma","volume":"13","year":"2017","journal-title":"Future Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","article-title":"Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma","volume":"378","author":"Motzer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.23736\/S2724-6051.23.05365-X","article-title":"Morbidity and mortality of metastasectomy for renal cell carcinoma: Is centralization of care the way forward?","volume":"75","author":"Marchioni","year":"2023","journal-title":"Minerva Urol. Nephrol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/13\/3332\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:00:03Z","timestamp":1760126403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/13\/3332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,25]]},"references-count":36,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["cancers15133332"],"URL":"https:\/\/doi.org\/10.3390\/cancers15133332","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,25]]}}}